Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria

British Journal of Dermatology

Volumn 147, Issue 4, 2002, Pages 760-764

  Vargas Diez E ^a   Chabas A ^b   Coll, M J ^b   Sanchez Perez J ^a   Garcia Diez A ^a   Fernandez Herrera J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Institut de Bioquimica Clinica Barcelona   (Spain)

Author keywords

Angiokeratoma corporis diffusum; Aspartylglucosaminidase; Aspartylglucosaminuria; Enzyme deficiency

Indexed keywords

LITHIUM; N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE;

ADULT; ARTICLE; ASPARTYLGLYCOSAMINURIA; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; FABRY DISEASE; FEMALE; HUMAN; MACROGLOSSIA; MANIC DEPRESSIVE PSYCHOSIS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SPAIN;

ACETYLGLUCOSAMINE; ADULT; ASPARTYLGLUCOSYLAMINASE; DISEASE PROGRESSION; FABRY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACROGLOSSIA; SKIN DISEASES, GENETIC;

EID: 0036408781     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04827.x     Document Type: Article

References (30)

1. Pollitt RJ, Jenner FA, Merskey H. Aspartylglucosaminuria an inborn error of metabolism associated with mental defect. Lancet 1968; ii: 253-5.
2. Autio S. Aspartylglucosaminuria. Analysis of thirty-four patients. J Ment Defic Res 1972; 1: 1-93.
3. Arvio M, Autio S, Louhiala P. Early clinical symptoms and incidence of aspartylglycosaminuria in Finland. Acta Paediatr 1993; 82: 587-9.
4. Gehler J, Sewell AC, Becker C et al. Clinical and biochemical delineation of aspartylglycosaminuria as observed in two members of an Italian family. Helv Paediatr Acta 1981; 36: 179-89.
5. Yoshida K, Ikeda SI, Yanagisawa N et al. Two Japanese cases with aspartylglycosaminuria: Clinical and morphological features. Clin Genet 1991; 40: 318-25.
6. Tsai MY, Marshall JG. Screening for urinary oligosaccharides and simple sugars by thin-layer chromatography. Med Lab Sci 1979; 36: 85-90.
7. Skoog WA, Beck WS. Studies in the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes. Blood 1956; 11: 436-54.
8. Voznyi YA, Keulemans JLM, Kleijer WJ et al. Applications of a new fluorimetric enzyme assay for the diagnosis of aspartylglucosaminuria. J Inher Metab Dis 1993; 16: 929-34.
9. Chabás A, Coll MJ, Aparicio M, Rodriguez Diaz E. Mild phenotypic expression of α-N-acetylgalactosaminidase deficiency in two adult siblings. J Inher Metab Dis 1994; 17: 724-31.
10. Wenger DA, Sattler M, Mueller T et al. Adult GM1 gangliosidosis. Clin Genet 1980; 17: 323-34.
11. Cooper A, Sarharwalla IB, Roberts MM. Human β-mannosidase deficiency. N Engl J Med 1986; 315: 1231.
12. Cooper A, Hatton C, Thornley M, Sarharwalla IB. Human β-mannosidase deficiency: Biochemical findings in plasma, fibroblasts, white cells and urine. J Inherit Metab Dis 1988; 11: 17-29.
13. Rodríguez-Serna M, Botella-Estrada R, Chabás A et al. Angiokeratoma corporis diffusum associated with β-mannosidase deficiency. Arch Dermatol 1996; 132: 1219-22.
14. Patel V, Watanabe I, Zeman W, Deficiency of aLfucosidase. Science 1972; 176: 420-7.
15. Epinnette WW, Norins AL, Drew AL et al. Angiokeratoma corporis diffusum with α-L-fucosidase deficiency. Arch Dermatol 1973; 107: 754-7.
16. Miyatake T, Atsumi T, Obayashi T et al. Adult type neuronal storage disease with neuraminidase deficiency. Ann Neurol 1978; 6: 232-44.
17. Kanzaki T, Yokota M, Irie F et al. Angiokeratoma corporis diffusum with glycopeptiduria due to deficient lysosomal α-N-acetylgalactosaminidase activity: Clinical, morphologic, and biochemical studies. Arch Dermatol 1993; 129: 460-5.
18. Keulemans JLM, Reuser AJJ, Kroos MA et al. Human α-N-acetylgalactosaminidase deficiency: New mutations and the paradox between genotype and phenotype. J Med Genet 1996; 33: 458-64.
19. Kodama K, Kobayashi H, Abe R et al. A new case of α-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum, with Ménière's syndrome and without mental retardation. Br J Dermatol 2001; 144: 363-8.
20. Holmes RC, Fensom AH, McKee P et al. Angiokeratoma corporis diffusum in a patient with normal enzyme activities. J Am Acad Dermatol 1984; 10: 384-7.
21. Crovato F, Revora A. Angiokeratoma corporis diffusum and normal enzyme activities. J Am Acad Dermatol 1985; 12: 885-6.
22. Calzavara-Pinton PG, Colombi M, Carlino A et al. Angiokeratoma corporis diffusum and arteriovenous fistulas with dominant transmission in the absence of metabolic disorders. Arch Dermatol 1995; 131: 57-62.
23. Arvio P, Arvio M, Pirinen S. Characteristic dental arches and dental occlusion in patients with aspartylglucosaminuria. J Craniofac Genet Dev Biol 1997; 17: 133-40.
24. Arvio P, Arvio M, Wolf J et al. Impaired oral health in patients with aspartyl glucosaminuria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 562-8.
25. Arvio P, Arvio M, Kero M et al. Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglycosaminuria. J Med Genet 1999; 36: 398-404.
26. Krivit W, Peters C, Shapiro EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglycosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999; 12: 167-76.
27. Autti T, Rapola J, Santavuori P et al. Bone marrow transplantation in aspartylglucosaminuria - Histopathological and MRI study. Neuropediatrics 1999; 30: 283-8.
28. Arvio M, Sauna-Aho O, Peippo M. Bone marrow transplantation for aspartylglucosaminuria: Follow-up study of transplanted and non-transplanted patients. J Pediatr 2001; 138: 288-90.
29. Dunder U, Kaartinen V, Valtonen P et al. Enzyme replacement therapy in a mouse model of aspartylglycosaminuria. FASEB J 2000; 14: 361-7.
30. Uusitalo A, Tenhunen K, Heinonen O et al. Toward understanding the neuronal pathogenesis of aspartylglucosaminuria: Expression of aspartylglucosaminidase in brain during development. Mol Genet Metabol 1999; 67: 294-307.